Novel methods for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2004228069 (hide)

Owner Cortical Pty Ltd

Inventors Iskander, Magdy Naguib; Morand, Eric Francis; Skene, Colin Edward

Agent Davies Collison Cave

Pub. Number AU-B-2004228069

PCT Pub. Number WO2004/089927

Priority 2003906773 08.12.03 AU; 2003901579 07.04.03 AU

Filing date 7 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 8 September 2011

International Classifications

C07D 317/20 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

A61K 31/085 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/385 (2006.01) - having two or more sulfur atoms in the same ring

A61K 31/39 (2006.01) - having oxygen atoms in the same ring

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 43/225 (2006.01) Ethers

C07D 213/69 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/02 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/04 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 251/04 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

C07D 263/10 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/12 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/04 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 317/12 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 317/16 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 317/22 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 317/30 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 317/34 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/089927 Priority application(s): WO2004/089927

8 September 2011 Application Accepted

  Published as AU-B-2004228069

19 January 2012 Standard Patent Sealed

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228070-Method and apparatus for control of plastics tube orientation process

2004228066-Method and apparatus for forming a document set